STAT3 and cancer: In this respect, our research has provided insights to the mechanisms mediating the joint activities of TME factors, revealing a duality in Y705-STAT3 influence on pro-metastatic characteristics of the cancer cells, as well as the ability of p65 to act as an inhibitor of CSC enrichment and to back up the missing protective activities of STAT3 in terms of CSC generation.